Epoch Biodesign
Develops biological recycling processes and commercial plants to break down and recover nylon 6.6 waste for circular material supply chains.
Overview
Epoch Biodesign develops biological recycling processes and commercial biorecycling plants to process nylon 6.6 waste, aiming to recover materials for circular supply chains. The company is focused on industrial-scale solutions within the polymer recycling market and positions its facilities as alternatives to mechanical or petrochemical routes for end-of-life nylon 6.6. Based in London, Epoch raised £9M from Extantia and Kompas VC in an undisclosed round announced 25 March 2026 to fund its largest nylon 6.6 biorecycling plant. The financing brings total disclosed capital to $13M across one round and is intended to support scale-up and plant deployment.
Funding History
London’s Epoch Biodesign raises £9M from Extantia and Kompas VC for its largest nylon 6.6 biorecycling plant
Frequently Asked Questions
- How much funding does AI Funding track for Epoch Biodesign?
- AI Funding tracks $13M for Epoch Biodesign across 1 funding round in this database.
- Who are Epoch Biodesign's investors?
- Epoch Biodesign's investors include Extantia, Kompas VC.
- What does Epoch Biodesign do?
- Epoch Biodesign develops biological recycling processes and commercial biorecycling plants to process nylon 6.6 waste, aiming to recover materials for circular supply chains. The company is focused on industrial-scale solutions within the polymer recycling market and positions its facilities as alternatives to mechanical or petrochemical routes for end-of-life nylon 6.6. Based in London, Epoch raised £9M from Extantia and Kompas VC in an undisclosed round announced 25 March 2026 to fund its largest nylon 6.6 biorecycling plant. The financing brings total disclosed capital to $13M across one round and is intended to support scale-up and plant deployment.
- Where is Epoch Biodesign headquartered?
- Epoch Biodesign is headquartered in London, UK.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.